BOCA RATON, FL--(Marketwire - May 29, 2008) - Vicor Technologies, Inc. (OTCBB: VCRT), focused on the commercialization of the PD2i Cardiac Analyzer, a patented device utilized in the risk stratification of patients for Sudden Cardiac Death (SCD), announces the addition of Jonathan Kaplan, M.D., M.P.H., to its Scientific Advisory Board.
